Literature DB >> 29517842

Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.

Jeong Yoon Yim1, Jinju Kim2,3, Donghee Kim4, Aijaz Ahmed4.   

Abstract

BACKGROUND & AIMS: Testosterone plays a role in predisposing individuals to cardiovascular and metabolic diseases, but its effects differ between men and women. We investigated the association between serum total testosterone and non-alcoholic fatty liver disease in adults in the US.
METHODS: A cross-sectional analysis of data from participants in the 2011-2012 National Health and Nutrition Examination Survey was performed. Subjects with significant alcohol consumption and those with viral hepatitis were excluded. We used the highest sex-specific quartiles of serum total testosterone as references. Suspected non-alcoholic fatty liver disease was diagnosed when serum alanine aminotransferase was >30 IU/L for men and >19 IU/L for women.
RESULTS: Of the 4758 subjects (49.4% men), the prevalence of suspected non-alcoholic fatty liver disease was inversely correlated with the sex-specific quartiles of testosterone in men and women. In a multivariate model, low total testosterone levels were associated with progressively higher odds of suspected non-alcoholic fatty liver disease in men after adjusting for age, obesity and other metabolic risk factors (P values for trends <.01). When the women were divided into 2 groups according to menopausal status, a significant correlation was observed only in the post-menopausal women (P values for trends <.01). The adjusted odds ratios for suspected non-alcoholic fatty liver disease were 1.72-1.99 in men and 2.15-2.26 in post-menopausal women (lowest quartile vs highest quartile).
CONCLUSIONS: In this nationally representative sample of adults in the US, low total testosterone levels were associated with suspected non-alcoholic fatty liver disease in men and post-menopausal women independent of known risk factors.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NAFLD; Testosterone; hepatic steatosis; menopause

Mesh:

Substances:

Year:  2018        PMID: 29517842     DOI: 10.1111/liv.13735

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  16 in total

Review 1.  Therapeutic pipeline in nonalcoholic steatohepatitis.

Authors:  Raj Vuppalanchi; Mazen Noureddin; Naim Alkhouri; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

2.  Correlation Between Sex Hormones and Non-alcoholic Fatty Liver Disease Before and After Laparoscopic Sleeve Gastrectomy.

Authors:  Diliqingna Dilimulati; Meili Cai; Ziwei Lin; Yuqin Zhang; Lei Du; Donglei Zhou; Jiangfan Zhu; Lili Su; Yu Wang; Manna Zhang; Shen Qu
Journal:  Obes Surg       Date:  2021-08-28       Impact factor: 3.479

3.  Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States.

Authors:  Ilya Golovaty; Phyllis C Tien; Jennifer C Price; Lila Sheira; Hilary Seligman; Sheri D Weiser
Journal:  J Nutr       Date:  2020-01-01       Impact factor: 4.798

Review 4.  Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.

Authors:  Hamza El Hadi; Angelo Di Vincenzo; Roberto Vettor; Marco Rossato
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

5.  Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia.

Authors:  Goh Eun Chung; Jeong Yoon Yim; Donghee Kim; Min Sun Kwak; Jong In Yang; Boram Park; Seong Joon An; Joo Sung Kim
Journal:  J Korean Med Sci       Date:  2020-06-08       Impact factor: 2.153

6.  Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease according to Different Menstrual Status Groups.

Authors:  Yanru Chen; Qiuping Huang; Ping Ai; Huamin Liu; Xueyu Chen; Xizhu Xu; Guoyong Ding; Yuejin Li; Xia Feng; Xiaohui Wang; Long Ji; Dong Li; Yong Zhou
Journal:  Can J Gastroenterol Hepatol       Date:  2019-11-23

7.  Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.

Authors:  Yu-Ming Wang; Ke-Fu Zhu; Wen-Jing Zhou; Qin Zhang; Dan-Feng Deng; Yi-Chen Yang; Wen-Wen Lu; Jia Xu; Yun-Mei Yang
Journal:  BMC Geriatr       Date:  2021-01-14       Impact factor: 3.921

8.  Sex-specific genetic effects across biomarkers.

Authors:  Emily Flynn; Yosuke Tanigawa; Fatima Rodriguez; Russ B Altman; Nasa Sinnott-Armstrong; Manuel A Rivas
Journal:  Eur J Hum Genet       Date:  2020-09-01       Impact factor: 4.246

Review 9.  NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment.

Authors:  Johanna K DiStefano
Journal:  Endocrinology       Date:  2020-10-01       Impact factor: 4.736

10.  Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.

Authors:  Kristin Alexandra Dayton; Fernando Bril; Diana Barb; Jinping Lai; Srilaxmi Kalavalapalli; Kenneth Cusi
Journal:  PLoS One       Date:  2021-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.